Abbott Laboratories

Abbott Laboratories Beats on EPS, Stock Down 3.03%

Abbott Laboratories reported an EPS of $0.98, slightly beating expectations. However, the stock fell by 3.03% following the earnings release, indicating that investors may have had concerns despite the EPS beat. Without additional context from management commentary or guidance, the market's reaction reflects uncertainty about the company's future performance.